GW572016 (lapatinib)

lapatinib · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW572016 (lapatinib), covering 2018-07-05 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: GW572016 to Treat Recurrent Malignant Brain Tumors [Phase 2]